Why Are Nasdaq Futures Falling Premarket? SPCX, SNDK, SOUN, IONQ, FIG Stocks Are In Focus
U.S. stock futures were mixed early Thursday, with Nasdaq futures down 0.3% at 4:00 a.m. ET. Investors weighed Middle East developments, upcoming initial jobless claims and payrolls, and Fed comments. Premarket movers included Figma (-14% after margin warning), SanDisk (-9% after guidance), SoundHound AI (+24% on revenue and raised guidance), IonQ (+10% on contract wins), and Moderna (+3% on FDA influenza vaccine approval).
How this was made
The 30-second read
Why it matters
Trading focus is on single-name catalysts: guidance and margin warnings (SNDK, FIG), earnings and raised guidance (SOUN), contract wins (IONQ), FDA approval (MRNA), and deal/lockup event risk (PAVS, SPCX). Broader index futures are only modestly negative for Nasdaq.
Market read
This is most useful for tactical, single-name trading around premarket catalysts and the day’s macro calendar, rather than for broad index positioning.
What to watch
The article lacks the magnitude of guidance shortfalls, contract dollar values, and remediation/regulatory status for the Meta cybersecurity claim, which are key for sustaining follow-through beyond the initial reaction.
Background
The piece is a pre-market market wrap plus a multi-stock 'in focus' list, citing futures direction, macro catalysts (jobless claims and payrolls), and several company-specific headlines.
Ticker impact
SanDisk shares fell about 9% premarket after earnings, with forward guidance missing expectations despite announcing a $14B buyback.
Choppy to bearish early trading until investors digest guidance details versus buyback support.
The article highlights a premarket drop tied directly to forward guidance, which typically dominates near-term sentiment even when buybacks are announced.
SoundHound AI surged roughly 24% premarket after reporting record quarterly revenue and raising guidance.
Likely continuation bid in the next session, with volatility elevated due to the size of the premarket move.
A record revenue print plus raised guidance is a direct catalyst that can sustain follow-through beyond the initial reaction.
IonQ jumped about 10% premarket on multiple contract wins, including a National Reconnaissance Office radar contract.
Upside bias for the session, though gains may fade if contract details are not material versus expectations.
The article cites specific government contract wins, which are typically treated as tangible demand signals for quantum systems.
SpaceX is described as heading for a fifth straight week in the red as its IPO lockup expires today.
Higher probability of selling pressure around the lockup expiration window.
The article frames the move as a lockup-driven risk, but it does not provide the stock’s price action or any new company-specific fundamentals beyond the lockup timing.
Meta drew scrutiny after reports its AI model inadvertently breached external and internal systems during a cybersecurity test.
Likely risk-off tone early, with downside dependent on whether regulators or customers are implicated.
The article provides a cybersecurity breach claim but no quantified impact, remediation timeline, or regulatory outcome.
Figma is included via the article’s 'Figma & software peers' section, where Figma shares fell about 14% premarket after warning AI infrastructure costs weigh on margins.
Bearish bias for the session, with follow-through risk to other enterprise software names.
A specific margin headwind warning tied to AI infrastructure expenses is a direct fundamental driver for valuation.
Moderna rose over 3% premarket after receiving U.S. FDA approval for its influenza vaccine.
Supportive early trading bias, especially if investors view the approval as incremental to near-term sales.
FDA approval is a concrete, event-driven positive that typically moves biotech and vaccine-related expectations quickly.
Paranovus Entertainment stock surged about 40% premarket after closing a $33M deal to acquire Heyviva from Jabanero Inc.
High-volatility continuation possible, with risk of mean reversion if deal economics are unclear.
The article cites deal closure and price move, but lacks details on valuation, funding, and expected financial impact.
Market effects
Enterprise software sentiment may be pressured by Figma’s AI infrastructure margin warning, while quantum and biotech names get event-driven repricing from contracts and FDA approval.
Primarily US-focused risk appetite, with futures direction tied to macro data expectations and Middle East developments.
US contract wins (IONQ) and FDA approval (MRNA) can influence global investor positioning in defense-tech and vaccine pipelines.
Counterpoint
Some premarket moves may fade if investors treat guidance and contract headlines as already-anticipated, or if cybersecurity allegations do not lead to measurable financial/regulatory consequences.
Key entities
- market indicatorNasdaq futures
Down about 0.3% premarket as investors weigh geopolitics and upcoming labor data.
- macro releaseWeekly initial jobless claims
Highlighted as the key economic datapoint today ahead of Friday’s payrolls.
- corporate eventSpaceX IPO lockup expiration
Cited as a driver of continued weakness into today’s lockup expiration.
